BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7979293)

  • 21. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum.
    Hata K; Kimura J; Miki H; Toyosawa T; Nakamura T; Katsu K
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2237-42. PubMed ID: 8891121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
    Sugar AM; Hitchcock CA; Troke PF; Picard M
    Antimicrob Agents Chemother; 1995 Mar; 39(3):598-601. PubMed ID: 7793858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
    Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
    J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of murine invasive candidiasis with amphotericin B and cilofungin: evidence for enhanced activity with combination therapy.
    Sugar AM; Goldani LZ; Picard M
    Antimicrob Agents Chemother; 1991 Oct; 35(10):2128-30. PubMed ID: 1759836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
    Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a new formulation of amphotericin B in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Espada R; Torrado J; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2008 Apr; 61(4):880-3. PubMed ID: 18256113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergy between cilofungin and amphotericin B in a murine model of candidiasis.
    Hanson LH; Perlman AM; Clemons KV; Stevens DA
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1334-7. PubMed ID: 1929290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
    Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C
    Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of SCH39304 in murine cryptococcosis.
    Restrepo BI; Ahrens J; Graybill JR
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1242-6. PubMed ID: 2552903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
    Lewis RE; Kontoyiannis DP; Darouiche RO; Raad II; Prince RA
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3499-505. PubMed ID: 12384356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
    Czaika V; Tietz HJ; Schmalreck A; Sterry W; Schultze W
    Mycoses; 2000; 43 Suppl 2():45-50. PubMed ID: 11291577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
    Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
    Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.